VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RLI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RLIRLI Corp.
$62.12$5.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRLIQuarterly Financials

RLI Corp. (RLI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

RLI Corp. (RLI) quarterly income statement — complete revenue, gross profit & net income history

RLI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue423.87M465.69M509.26M499.83M407.67M439.12M470M416.44M444.83M445.37M331.69M381.86M364.92M366.48M859.49M213.09M264.81M327.67M270.47M298.08M
Revenue Growth %3.98%6.05%8.36%20.02%-8.36%-1.4%41.7%9.06%21.9%21.53%-61.41%79.2%37.8%11.84%217.78%-28.51%-7.84%6.21%2.91%-0.06%
Medical Costs & Claims193.24M306.4M347.15M339.67M327.8M374.93M348.8M309.04M282.98M143.62M314.16M281.08M239.83M109.79M282.67M226.85M209.67M81.19M239.66M204.41M
Medical Cost Ratio %45.59%65.79%68.17%67.96%80.41%85.38%74.21%74.21%63.62%32.25%94.71%73.61%65.72%29.96%32.89%106.46%79.18%24.78%88.61%68.58%
Gross Profit230.63M159.29M162.11M160.15M79.87M64.18M121.2M107.4M161.85M301.75M17.53M100.78M125.09M256.68M576.82M-13.76M55.14M246.47M30.8M93.67M
Gross Margin %54.41%34.21%31.83%32.04%19.59%14.62%25.79%25.79%36.38%67.75%5.29%26.39%34.28%70.04%67.11%-6.46%20.82%75.22%11.39%31.42%
Gross Profit Growth %188.77%148.19%33.76%49.12%-50.65%-78.73%591.3%6.57%29.39%17.56%-96.96%832.33%126.86%4.14%1772.49%-114.69%-37.8%8.59%-34.92%-17.6%
Operating Expenses163.28M33.41M4.87M3.64M1.24M16.75M4.37M4.1M1.86M158.33M2.51M4.75M2.3M142.68M22.12M-7.21M-3.39M129.44M-4.63M-8.35M
OpEx / Revenue %38.52%7.17%0.96%0.73%0.3%3.81%0.93%0.98%0.42%35.55%0.76%1.24%0.63%38.93%2.57%-3.38%-1.28%39.5%-1.71%-2.8%
Depreciation & Amortization00000000000000000000
Combined Ratio %84.11%72.97%69.12%68.69%80.71%89.2%75.14%75.19%64.03%67.8%95.47%74.85%66.35%68.89%35.46%103.08%77.9%64.28%86.9%65.77%
Operating Income67.34M125.88M157.25M156.51M78.63M47.43M116.83M103.3M159.99M143.42M15.02M96.03M122.79M114M554.7M-6.55M58.52M117.03M35.44M102.02M
Operating Margin %15.89%27.03%30.88%31.31%19.29%10.8%24.86%24.81%35.97%32.2%4.53%25.15%33.65%31.11%64.54%-3.08%22.1%35.72%13.1%34.23%
Operating Income Growth %-14.36%165.39%34.6%51.51%-50.85%-66.93%677.85%7.57%30.3%25.8%-97.29%1565.23%109.81%-2.58%1465.32%-106.42%-34.85%13.82%-31.2%-11.19%
EBITDA69.69M125.88M158.61M157.87M79.97M48.92M118.44M104.91M161.61M144.8M16.89M98.08M124.8M116.02M556.72M-4.54M60.53M119M37.34M103.92M
EBITDA Margin %16.44%27.03%31.14%31.58%19.62%11.14%25.2%25.19%36.33%32.51%5.09%25.68%34.2%31.66%64.77%-2.13%22.86%36.32%13.81%34.86%
Interest Expense2.35M1.31M1.36M1.35M1.33M1.49M1.62M1.6M1.62M1.37M1.87M2.05M2.01M2.01M2.01M2.01M2.01M1.97M1.91M1.9M
Non-Operating Income-2.35M0-1.36M-1.35M-1.33M-1.49M-1.62M-1.6M-1.62M-1.37M-1.87M-2.05M-2.01M-2.01M-2.01M-2.01M-2.01M-1.97M-1.91M-1.9M
Pretax Income67.34M113.59M157.25M156.51M78.63M47.43M116.83M103.3M159.99M143.42M15.02M96.03M122.79M114M554.7M-6.55M58.52M117.03M35.44M102.02M
Pretax Margin %15.89%24.39%30.88%31.31%19.29%10.8%24.86%24.81%35.97%32.2%4.53%25.15%33.65%31.11%64.54%-3.08%22.1%35.72%13.1%34.23%
Income Tax12.46M22.41M32.63M32.18M15.42M6.57M21.8M21.31M32.09M28.81M1.48M18.38M23.98M16.17M114.81M-4.32M10.6M21.75M6.19M20.21M
Effective Tax Rate %18.5%19.73%20.75%20.56%19.61%13.86%18.66%20.63%20.06%20.09%9.87%19.14%19.53%14.18%20.7%65.84%18.12%18.58%17.48%19.81%
Net Income54.88M91.18M124.61M124.34M63.21M40.86M95.03M81.99M127.9M114.61M13.54M77.65M98.81M97.83M439.89M-2.24M47.92M95.28M29.24M81.81M
Net Margin %12.95%19.58%24.47%24.88%15.51%9.31%20.22%19.69%28.75%25.73%4.08%20.34%27.08%26.7%51.18%-1.05%18.1%29.08%10.81%27.45%
Net Income Growth %-13.18%123.14%31.13%51.64%-50.58%-64.35%602.03%5.59%29.44%17.15%-96.92%3568.16%106.19%2.68%1404.27%-102.74%-34.36%13.7%-31.01%-11.23%
EPS (Diluted)0.600.991.351.340.680.441.030.891.391.250.150.851.081.074.81-0.020.531.040.320.90
EPS Growth %-11.76%125%31.07%50.56%-51.08%-64.8%586.67%5.33%29.3%17.37%-96.88%3521.05%104.76%2.4%1401.56%-102.76%-34.38%13.04%-31.18%-12.25%
EPS (Basic)0.600.991.351.350.690.451.030.901.401.250.150.851.091.084.85-0.020.531.050.330.91
Diluted Shares Outstanding92.19M92.22M92.31M92.52M92.53M92.45M92.44M92.36M92.33M92.14M92.13M92.09M92.07M91.91M91.55M90.74M91.43M91.46M91.38M91.43M